BlackRock Fund Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

BlackRock Fund Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$15.6M	Buy	7,359,385 +957,970	+15%	+$2.67M	﹤0.01%	2319
2016 Q3	$21.4M	Buy	6,401,415 +404,722	+7%	+$1.28M	﹤0.01%	2032
2016 Q2	$18.8M	Buy	5,996,693 +86,207	+1%	+$287K	﹤0.01%	2058
2016 Q1	$19.7M	Sell	5,910,486 -6,526,309	-52%	-$20.3M	﹤0.01%	1999
2015 Q4	$44M	Sell	12,436,795 -259,248	-2%	-$1.09M	0.01%	1562
2015 Q3	$63.9M	Sell	12,696,043 -269,609	-2%	-$1.54M	0.02%	1259
2015 Q2	$83.4M	Sell	12,965,652 -398,269	-3%	-$2.67M	0.02%	1143
2015 Q1	$94M	Buy	13,363,921 +1,060,008	+9%	+$7.68M	0.02%	1050
2014 Q4	$94.9M	Buy	12,303,913 +760,318	+7%	+$6.02M	0.02%	996
2014 Q3	$86.2M	Buy	11,543,595 +159,415	+1%	+$1.48M	0.02%	963
2014 Q2	$110M	Sell	11,384,180 -127,315	-1%	-$1.13M	0.03%	799
2014 Q1	$95.7M	Buy	11,511,495 +686,216	+6%	+$5.88M	0.03%	878
2013 Q4	$91.4M	Buy	10,825,279 +196,489	+2%	+$1.66M	0.03%	905
2013 Q3	$84.7M	Buy	10,628,790 +722,942	+7%	+$5.81M	0.03%	893
2013 Q2	$76.5M	Buy	+9,905,848	New	+$77.2M	0.03%	851

Other funds holding PDLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BlackRock Fund Advisors's PDLI Position: Q4 2016 in Review

BlackRock Fund Advisors increased its PDL BioPharma, Inc. (PDLI) stake by 15% in Q4 2016, buying an estimated $2.67M and bringing the position to 7,359,385 shares worth $15.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2319.

BlackRock Fund Advisors first reported a position in PDLI in Q2 2013 and has held it in 15 quarters since. The position peaked at $110M in Q2 2014. 190 funds tracked by Wall St. Rank hold PDLI as of Q4 2016.

BlackRock Fund Advisors held 7,359,385 shares of PDL BioPharma, Inc. worth $15.6M as of Q4 2016.
BlackRock Fund Advisors bought 957,970 PDL BioPharma, Inc. shares in Q4 2016, an estimated $2.67M.
PDL BioPharma, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2319 holding.
BlackRock Fund Advisors first reported a position in PDL BioPharma, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's PDL BioPharma, Inc. position peaked at $110M in Q2 2014.
190 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.